 Phoenix, Arizona--Newsfile Corp. - January 20, 2021 - The Stock Day Podcast welcomed Silo Pharma Inc. OTCQB: SILO the Company, a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as depression, PTSD, Parkinsons, and other rare neurological disorders. CEO of the Company, Eric Weisblum, joined Stock Day host Everett Jolly. Personally, I have over 20 years of experience investing and working in the private and... 